Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests
| Autor: | Tyler R. Ross, Terry S. Field, Andrew E. Williams, Sheila Weinmann, Christopher L. Owens, Diana S. M. Buist, Daniel J. Peterson, Kenneth Adams, Azadeh Stark, Aruna Kamineni, Chyke A. Doubeni |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Gynecology
Cancer Research medicine.medical_specialty biology medicine.diagnostic_test business.industry Papanicolaou stain Papanicolaou Test Cervical intraepithelial neoplasia medicine.disease Negative Test Result biology.organism_classification female genital diseases and pregnancy complications Oncology Internal medicine medicine Clinical significance Pap test Risk factor Papillomaviridae business |
| Zdroj: | Cancer Cytopathology. 123:59-65 |
| ISSN: | 1934-662X |
| Popis: | BACKGROUND To the authors' knowledge, few studies to date have examined adherence to recommended guidelines for follow-up and outcomes after an unsatisfactory Papanicolaou (Pap) test (UPT) with liquid-based technologies. METHODS Within 4 US health plans, the median time to follow-up and the percentage of patients with follow-up testing by 120 days was calculated after a UPT. Multivariable analyses evaluated the association between clinical factors and follow-up testing. The authors compared the risk of a diagnosis of cervical intraepithelial neoplasia of type 2 or worse (CIN2+) after a UPT with the risk after a satisfactory Pap test while controlling for study site, test year, and other covariates. RESULTS A total of 634,644 Pap tests performed between 2004 and 2010 were included in the current study. Of 1442 UPTs, 53.4% had follow-up testing within 120 days; follow-up differed across the health plans (P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text